"More Than Meets The Eye" The Eye in Systemic Disease - Symposium 2019
Date: 4/05/2019
Venue: The Novotel North Wollongong 2-14 Cliff Road, NSW, 2500
Provider: Southern Ophthalmology
Contact: Kim Campion, [E] kimcampion@suresight.com.au, [P] 0424755917
Learning Objectives
- At the completion of the CPD activity, participants should be able to understand the clinical application of retinal imaging techniques (including OCT-angiography (OCTA) in the management of retinal diseases
- At the completion of the CPD activity, participants should be able to have a better understanding of recent developments in Glaucoma
- At the completion of the CPD activity, participants should be able to have a better understanding of minimally invasive glaucoma surgery and lifestyle factors that may impact on glaucoma
- At the completion of the CPD activity, participants should be able to identify the symptoms of Central Serous Retinopathy (CSR)
- At the completion of the CPD activity, participants will have a better understanding of the treatment/management plan provided for Central Serous Retinopathy (CSR) patients
- At the completion of the CPD activity, participants should be able to identify eye drops that help protect the the optic nerve can be toxic to the ocular surface
- At the completion of the CPD activity, participants should be able to identify ocular surface issues associated with glaucoma drops can make the patient more comfortable and reduce the risk of vision threatening ocular surface disease.
- At the completion of the CPD activity, participants should be able to understand the options for cataract surgery in patients with coexisting corneal disease
- At the completion of the CPD activity, participants should be able to gain an insight into lens selection options for patients with and without corneal pathology
- At the completion of the CPD activity, participants should be able to understand the benefits of newer technologies for improving our postoperative outcomes for cataract surgery
- At the completion of the CPD activity, participants should be able to understand the principle of treatment amblyopia and squint in children
- At the completion of the CPD activity, participants should be able to understand treatment options in patients with double vision
- At the completion of the CPD activity, participants should be able to understand the benefits and timing of squint surgery in children with amblyopia
- At the completion of the CPD activity, participants should be able to discuss the clinical findings of laser induced maculopathy, Valsalva retinopathy and poppers maculopathy as causes of sudden visual loss.
Max points awarded: 10.50
Session Information
| Name |
|---|
| Clinical Cases highlighting diagnostic and management advances in AMD and Diabetic retinopathy |
| Activity Type |
| Face to Face with Assessment |
| Therapeutic? |
| No |
| Manufacturer/Supplier? |
| No |
| Points for attending & Passing Assessment |
| 1.50 |
| Name |
|---|
| Glaucoma in 2019 – MIGS, meditation and more ........ |
| Activity Type |
| Face to Face with Assessment |
| Therapeutic? |
| Yes |
| Manufacturer/Supplier? |
| No |
| Points for attending & Passing Assessment |
| 1.50 |
| Name |
|---|
| Update on Central Serous Retinopathy (CSR) |
| Activity Type |
| Face to Face with Assessment |
| Therapeutic? |
| No |
| Manufacturer/Supplier? |
| No |
| Points for attending & Passing Assessment |
| 1.50 |
| Name |
|---|
| Managing occular surface issues caused by vision preserving glaucoma drops |
| Activity Type |
| Face to Face with Assessment |
| Therapeutic? |
| Yes |
| Manufacturer/Supplier? |
| No |
| Points for attending & Passing Assessment |
| 1.50 |
| Name |
|---|
| Cataract surgery in corneal disease |
| Activity Type |
| Face to Face with Assessment |
| Therapeutic? |
| No |
| Manufacturer/Supplier? |
| No |
| Points for attending & Passing Assessment |
| 1.50 |
| Name |
|---|
| Whats new and important in paediatric Ophthalmology in 2019 |
| Activity Type |
| Face to Face with Assessment |
| Therapeutic? |
| No |
| Manufacturer/Supplier? |
| No |
| Points for attending & Passing Assessment |
| 1.50 |
| Name |
|---|
| “Vision loss after a night out on the town” |
| Activity Type |
| Face to Face with Assessment |
| Therapeutic? |
| No |
| Manufacturer/Supplier? |
| No |
| Points for attending & Passing Assessment |
| 1.50 |
| Name | Activity Type | Therapeutic? | Manufacturer/ Supplier? | Points for attending & Passing Assessment |
|---|---|---|---|---|
| Clinical Cases highlighting diagnostic and management advances in AMD and Diabetic retinopathy | Face to Face with Assessment | No | No | 1.50 |
| Glaucoma in 2019 – MIGS, meditation and more ........ | Face to Face with Assessment | Yes | No | 1.50 |
| Update on Central Serous Retinopathy (CSR) | Face to Face with Assessment | No | No | 1.50 |
| Managing occular surface issues caused by vision preserving glaucoma drops | Face to Face with Assessment | Yes | No | 1.50 |
| Cataract surgery in corneal disease | Face to Face with Assessment | No | No | 1.50 |
| Whats new and important in paediatric Ophthalmology in 2019 | Face to Face with Assessment | No | No | 1.50 |
| “Vision loss after a night out on the town” | Face to Face with Assessment | No | No | 1.50 |
This is a test only